Laura F. Laemmle-Weidenfeld

Partner

Washington + 1.202.879.3496

Laura Laemmle-Weidenfeld has successfully defended health care and life sciences clients against False Claims Act (FCA) cases and other government enforcement actions, including actions focused on the Anti-Kickback Statute (AKS) and physician self-referral law (Stark Law), for more than 20 years. She has represented health care providers and practitioners, digital health entities, distributors, and pharmaceutical and medical device manufacturers against health care fraud investigations and litigation initiated by the U.S. Department of Justice (DOJ), U.S. Attorney's Offices, private whistleblowers, the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG), and state attorneys general.

Laura also draws on her enforcement experience to provide clients with practical advice regarding compliance with health care fraud and abuse laws, particularly under the AKS, Stark Law, and FCA. In addition, she helps clients conduct internal investigations, prepare and negotiate self-disclosures to regulators including HHS-OIG and the Centers for Medicare and Medicaid Services (CMS), and obtain advisory opinions from HHS-OIG. She also helps clients negotiate and navigate corporate integrity agreements (CIAs) with HHS-OIG and counsels clients on creating and maintaining effective compliance programs.

Earlier in her career, Laura led health care FCA investigations and litigation, including those brought under the FCA's qui tam (whistleblower) provisions, at the DOJ's Civil Division.

Laura frequently writes and speaks on health care enforcement issues. She is a member of the American Health Law Association's (AHLA) Board and is the author of Legal Issues in Health Care Fraud and Abuse, Fifth Edition, and its annual supplements, published by the AHLA.